Three clinical trials demonstrated that initiating ART early during TB treatment (within 2–4 weeks) greatly increases AIDS-free survival by 34–68% among individuals with advanced HIV disease (6–8), and World Health Organization (WHO) guidelines recommend ART initiation for all PLHIV as soon as possible after TB treatment initiation, regardless of CD4+ count (9). Here, CD4 is linked to tuberculosis.